These biological pathways tend to impact response reactions against intracellular or extracellular stimulations and suggest a functional link between KDM6B and clinical diseases, including inflammations, especially, cancers (Zhang et al., 2018; Mallaney et al., 2019; Cao et al., 2021). Here, KDM6B is linked to cancer.